EMvision Medical Devices Ltd
ASX:EMV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (13.8), the stock would be worth AU$-1.33 (174% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -18.8 | AU$1.81 |
0%
|
| Industry Average | 13.8 | AU$-1.33 |
-174%
|
| Country Average | 13.2 | AU$-1.27 |
-170%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
EMvision Medical Devices Ltd
ASX:EMV
|
166.8m AUD | -18.8 | -16.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
161B USD | 16.7 | 25.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.3B USD | 56.9 | 60.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 25 | 38.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.2B USD | 14.6 | 23.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
88.3B USD | 21.1 | 33.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.6B EUR | 13.7 | 19.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 29.6 | 44 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 38.9 | 43.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 13 | 25.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.9B USD | 16.3 | 15.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.9 |
| Median | 13.2 |
| 70th Percentile | 19.2 |
| Max | 8 864.3 |
Other Multiples
EMvision Medical Devices Ltd
Glance View
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.
